Filter posts

Open Communication Helps Reduce Rare Disease Drug Development Risk

One of the most important keys to successful relationships – be it in life or …

Cancer Insurance Checklist: Guía de Cobertura Médica para Personas con Cáncer

As the world marks World Cancer Day and the U.S. continues to implement the Affordable …

FDA Check-Up: Drug Development and Manufacturing Challenges

I have over 27 years of experience in the biotechnology and pharmaceutical industry. My current …

The Arrival of Actionable Personalized Medicine

The pace of implementation of next-generation sequencing (NGS) in a clinical context, which almost rivals …

New Cancer Treatments Seek to Give the Immune System Superpowers

Melanoma is scary. It is aggressive, spreads quickly to far-away organs with the stealth and …

JOBS Act Deconstructed: Regulation A

More than 40 biotech companies have gone public using provisions made available to emerging growth …

Fighting Blindness through Sound Investments in Research

Since 1971, the Foundation Fighting Blindness has raised more than half a billion dollars in …

Uniting To Accelerate Pediatric Medicine

Drug companies inherently absorb significant risk when developing compounds and biologics for clinical use. A …

“Should the USPTO allow the patenting of living organisms?”

Most people associate patents with mechanical or electronic devices, new chemical substances, intricate machines or …

CTTI: Use of Central IRBs in Multi-Center Trials to Streamline Clinical Research

Multi-center clinical trials can provide high-quality, statistically-sound evidence to answer medical questions. Earlier this year, …